Rupture of a Small Hepatocellular Carcinoma in a Stable Disease State in a Patient Receiving Sorafenib Treatment

Chin Med J (Engl). 2018 Apr 20;131(8):999-1000. doi: 10.4103/0366-6999.229907.

Authors

Rumiko Tsuboi¹, Takeharu Asano¹, Katsuhiko Matsuura², Shinichi Asabe¹, Hirosato Mashima¹

Affiliations

¹ Department of Gastroenterology, Saitama Medical Center, Jichi Medical University, Saitama 330-8503, Japan.
² Department of Radiology, Saitama Medical Center, Jichi Medical University, Saitama 330-8503, Japan.

No abstract available

Publication types

Letter

MeSH terms

Antineoplastic Agents / therapeutic use*
Carcinoma, Hepatocellular / drug therapy*
Carcinoma, Hepatocellular / pathology
Humans
Liver Neoplasms / drug therapy*
Liver Neoplasms / pathology
Niacinamide
Phenylurea Compounds
Rupture
Sorafenib / therapeutic use*
Treatment Outcome

Substances

Antineoplastic Agents
Phenylurea Compounds
Niacinamide
Sorafenib